Parameter Age, years 54 (45–76) Male, (%) 18 (78%) Liver disease etiology, (%) HCV 9 (39%) HCV/HIV 9 (39%) HIV/NASH 5 (22%) Body mass index, kg/m2 30 (21–46) >30 kg/m2 (obesity), (%) 12 (52%) Laboratory studies Platelets, K/uL 159 (45–284) Alkaline phosphatase, U/L 107 (51–210) Aspartate aminotransferase (AST), U/L 56 (22–151) Alanine aminotransferase (ALT), U/L 77 (30–161) Total bilirubin, mg/dL 0.8 (0.3–2.3) Direct bilirubin, mg/dL 0.3 (0.1–1.4) Gamma-glutamyl transferase (GGT), U/L 150 (19–531) Albumin, g/dL 4.1 (3.0–5.5) Prothrombin time (PT), seconds 14.3 (12.3–16.4) International normalized ratio (INR) 1.1 (0.9–1.3) Hepatitis C characteristics ( ) HCV viral load, , IU/mL 6.9 (4.7–7.8) Hepatitis C genotype, (%) 1a 13 (72) 1b 3 (17) 2 1 (6) 4 1 (6) MRE shear wave velocity, m/sec ( ) 2.13 (1.25–3.03) HVPG, mmHg 6 (3–16) Liver biopsy length, mm 12 (6–24) <10 mm, (%) 6 (26) Liver biopsy scoring Fibrosis, Ishak (range 0–6) 4 (1–6) Inflammation, total HAI (range 0–18) 8 (1–14) Steatosis (range 0–4) 1 (0–2)